Skip to main content

Table 1 Patients and Transplants Characteristic

From: Prognostic factors of survival time after hematopoietic stem cell transplant in acute lymphoblastic leukemia patients: Cox proportional hazard versus accelerated failure time models

Characteristic

Frequency (%)

D onor-recipient sex match-no. (%)

 

   Male-male

85(41.3)

   Male-female

54(26.2)

   Female-male

36(17.5)

   Female-female

31(15)

A ge Mean(SD)

22.5(8.73)

A ge(years), Median(range)

20(2–51)

D onor age, Median(range)

21(2–55)

A ge group – no. (%)

 

   < 15 yr

37(18)

   16–20 yr

72(35)

   21–30 yr

64(31.1)

   31–40 yr

22(10.7)

   > 40 yr

11(5.3)

O utcomes-no. (%)

 

   Death

76(39.9)

   Relapse

59(28.6)

   aGVHD

136(77.7)

   cGVHD

34(24.1)

   Platelet recovery

141(75.0)

   Neutrophil recovery

167(85.6)

T ime of aGVHD-day

 

   Mean(SD)

13.3(16.5)

   Median

9

   Range

3–90

T ime of cGVHD-day

 

   Mean(SD)

160.26(73.4)

   Median

140

   Range

91–327

T ime of relapse-day

 

   Mean(SD)

580(555)

   Median

412

   Range

10–2661

T ime of platelet recovery-day

 

   Mean(SD)

20.8(19.2)

   Median

17

   Range

1–165

T ime of neutrophil recovery-day

 

   Mean(SD)

13.46(12.8)

   Median

11

   Range

1–160

F ollow up-month

 

   Median

16

   range

3–89

  1. aGVHD, acute graft-versus-host disease; cGVHD, chronic graft-versus-host disease